Element Biosciences, Inc. Sustainability Profile
Element Biosciences, Inc., headquartered in the United States, is a pioneering company in the genomics industry, specialising in innovative DNA sequencing technologies. Founded in 2017, Element has rapidly established itself as a leader in the field, focusing on providing accessible and cost-effective solutions for researchers and clinicians alike. The company’s flagship product, the Element AVITI System, offers a unique approach to next-generation sequencing, combining high throughput with exceptional accuracy. This technology is designed to meet the diverse needs of the genomics community, enabling advancements in areas such as personalised medicine and genetic research. With a commitment to transforming the landscape of DNA sequencing, Element Biosciences has garnered significant attention for its cutting-edge innovations and strategic partnerships, positioning itself as a formidable player in the rapidly evolving genomics market.
DitchCarbon Score
How does Element Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Element Biosciences, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Element Biosciences, Inc.'s reported carbon emissions
Element Biosciences, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Element Biosciences does not appear to have established any significant climate commitments or initiatives at this time. The lack of emissions data and reduction strategies suggests that the company may still be in the early stages of developing its climate action framework. In the broader context of the industry, many organisations are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. Element Biosciences may benefit from aligning with these industry standards in the future to enhance its climate commitments.
How Carbon Intensive is Element Biosciences, Inc.'s Industry?
How Carbon Intensive is Element Biosciences, Inc.'s Location?
Element Biosciences, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Element Biosciences, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
